Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026)
Treace Medical Concepts (TMCI) reported Short term Debt of $1.8 million for Q1 2026, up 3846.67% on a YoY basis from $45000.0 in Q1 2025, and up 1.78% quarter-over-quarter from $1.7 million in Q4 2025.
Treace Medical Concepts (TMCI) Short term Debt (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported Short term Debt for 3 years, with the latest figure at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Short term Debt rose 3846.67% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 3846.67% YoY), and the FY2025 full-year result was $1.7 million, changed N/A from the prior year.
- Short term Debt for Q1 2026 stood at $1.8 million, up from $1.7 million in the prior quarter.
- The five-year high for Short term Debt was $1.8 million in Q3 2025, with the low at $45000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2020 | 1.79 Mn |